RESTORING LOWER-LIMB BLOOD-FLOW IMPROVES CONDUCTION-VELOCITY IN DIABETIC-PATIENTS

被引:10
作者
YOUNG, MJ
VEVES, A
SMITH, JV
WALKER, MG
BOULTON, AJM
机构
[1] UNIV MANCHESTER,MANCHESTER ROYAL INFIRM,DEPT MED,MANCHESTER M13 9WL,LANCS,ENGLAND
[2] MANCHESTER ROYAL INFIRM,DEPT VASC SURG,MANCHESTER M13 9WL,LANCS,ENGLAND
关键词
PERIPHERAL NEUROPATHY; PERIPHERAL VASCULAR DISEASE;
D O I
10.1007/s001250050390
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Human diabetic peripheral neuropathy is believed to have, at least in part, a microvascular basis. This study was designed to examine the effects of restoration of arterial blood supply on peripheral nerve function in six non-insulin-dependent diabetic patients with peripheral occlusive vascular disease. In the revascularised legs, transcutaneous oxygen increased from a median 37.5 (28.5-45.7 interquartile range) mmHg to 55.5 (53.5-62.5) mmHg, p = 0.036, mean increase 20.2 (14.8-25.6, 95 % confidence intervals(CI)) mmHg. This was accompanied by a significant improvement in peroneal motor nerve conduction velocity from 31.7 (26.5-36.3) m/s to 33.5 (32.9-39.4) m/s, p = 0.04, mean increase 4.7 (1.7-7.7, 95 % CI) m/s. There was no significant change in transcutaneous oxygen or peroneal nerve motor conduction velocity in the contralateral control limbs. This improvement in conduction velocity with improved tissue oxygenation suggests that studies of agents which might indirectly bring about improvements in microvascular blood flow should be urgently considered.
引用
收藏
页码:1051 / 1054
页数:4
相关论文
共 16 条
[1]   A MULTICENTER TRIAL OF THE ALDOSE-REDUCTASE INHIBITOR, TOLRESTAT, IN PATIENTS WITH SYMPTOMATIC DIABETIC NEUROPATHY [J].
BOULTON, AJM ;
LEVIN, S ;
COMSTOCK, J .
DIABETOLOGIA, 1990, 33 (07) :431-437
[2]   POTENTIAL THERAPEUTIC APPROACHES TO THE TREATMENT OR PREVENTION OF DIABETIC NEUROPATHY - EVIDENCE FROM EXPERIMENTAL STUDIES [J].
CAMERON, NE ;
COTTER, MA .
DIABETIC MEDICINE, 1993, 10 (07) :593-605
[3]  
JACOBS HJH, 1990, EUR J VASCULAR SURG, V4, P525
[4]   TREATMENT OF DIABETIC NEUROPATHY WITH GAMMA-LINOLENIC ACID [J].
KEEN, H ;
PAYAN, J ;
ALLAWI, J ;
WALKER, J ;
JAMAL, GA ;
WEIR, AI ;
HENDERSON, LM ;
BISSESSAR, EA ;
WATKINS, PJ ;
SAMPSON, M ;
GALE, EAM ;
SCARPELLO, J ;
BODDIE, HG ;
HARDY, KJ ;
THOMAS, PK ;
MISRA, P ;
HALONEN, JP .
DIABETES CARE, 1993, 16 (01) :8-15
[5]   EPIDEMIOLOGICAL CORRELATES OF DIABETIC NEUROPATHY - REPORT FROM PITTSBURGH EPIDEMIOLOGY OF DIABETES COMPLICATIONS STUDY [J].
MASER, RE ;
STEENKISTE, AR ;
DORMAN, JS ;
NIELSEN, VK ;
BASS, EB ;
MANJOO, Q ;
DRASH, AL ;
BECKER, DJ ;
KULLER, LH ;
GREENE, DA ;
ORCHARD, TJ .
DIABETES, 1989, 38 (11) :1456-1461
[6]   SURAL NERVE OXYGEN-TENSION IN DIABETES [J].
NEWRICK, PG ;
WILSON, AJ ;
JAKUBOWSKI, J ;
BOULTON, AJM ;
WARD, JD .
BRITISH MEDICAL JOURNAL, 1986, 293 (6554) :1053-1054
[7]   VASCULAR INSUFFICIENCY QUANTITATIVELY AGGRAVATES DIABETIC NEUROPATHY [J].
RAM, Z ;
SADEH, M ;
WALDEN, R ;
ADAR, R .
ARCHIVES OF NEUROLOGY, 1991, 48 (12) :1239-1242
[8]  
REA A, 1993, DIABETIC MED, V10, pS18
[9]   UPPER EXTREMITY ISCHEMIC MONOMELIC NEUROPATHY - A COMPLICATION OF VASCULAR ACCESS PROCEDURES IN UREMIC DIABETIC-PATIENTS [J].
RIGGS, JE ;
MOSS, AH ;
LABOSKY, DA ;
LIPUT, JH ;
MORGAN, JJ ;
GUTMANN, L .
NEUROLOGY, 1989, 39 (07) :997-998
[10]   PERIPHERAL NEUROPATHY AFTER CHRONIC ENDONEURIAL ISCHEMIA [J].
SLADKY, JT ;
TSCHOEPE, RL ;
GREENBERG, JH ;
BROWN, MJ .
ANNALS OF NEUROLOGY, 1991, 29 (03) :272-278